Value Evaluation Frameworks: How Can They Meet The Challenge?Rising health care

costs and pharmaceutical costs in particular are among the main aspects that have triggered a steady flow of scholarly and ordinary press articles about moving from spending for volume to spending for worth. Propositions from groups such as the Center for American Progress advocate drug prices based on evaluations of relative effectiveness. If carried out, value-based assessments of drugs and other healthcare services would affect payer, provider, and client choice making, and likely client results too. Each of these techniques presumes that some calculus of value could dependably be determined, would use to a lot of patients and other stakeholders, and could inform healthcare choices. As prior Health Affairs Post have talked about, a variety of worth assessment fra … See all stories on this topic

By |March 3rd, 2017|NCAS|0 Comments

About the Author:

Leave A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.